ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,667.56
0.08%
Dow Jones
41,985.35
0.08%
US Dollar vs MXN
20.2392
0.00%
Brent Oil
71.775
0.00%
Bitcoin
84,154.57
0.13%
Pepperstone
Advertisement
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ

  6. Telomir Pharmaceuticals Inc (TELO) Cotización

Telomir Pharmaceuticals Inc

Telomir Pharmaceuticals Inc (TELO)

Telenor ASA
Telenor ASA
Telenor ASA
Telenor ASA
Telo Genomics Corporation
4.56
0.48
(11.76%)
Cerrado 22 Marzo 2:00PM
Delayed by 15 minutes
4.49
-0.07
(-1.54%)
Fuera de horario: 5:55PM
Delayed by 15 minutes

Su centro para precios en tiempo real, ideas y debates en vivo

Premium

Estadísticas y detalles clave

Último Precio
4.49
Postura de Compra
4.20
Postura de Venta
4.39
Volume Operado de la Acción
670,839
3.90 Rango del Día 4.63
3.11 Rango de 52 semanas 9.39
Capitalización de Mercado [m]
133.634M
Precio Anterior
4.08
Precio de Apertura
4.06
Hora
1
@
4.39
Última hora de negociación
Volumen financiero
US$ 2,763,506
Precio Promedio Ponderado
4.1195
Volumen promedio (3 m)
130,083
Acciones en circulación
29,762,671
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-7.97
Beneficio por acción (BPA)
-0.56
turnover
-
Beneficio neto
-16.53M

Acerca de Telomir Pharmaceuticals Inc

Telomir Pharmaceuticals, Inc. is a pre-clinical-stage pharmaceutical company focused on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells. Its goal is to develop and commercialize new t... Telomir Pharmaceuticals, Inc. is a pre-clinical-stage pharmaceutical company focused on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells. Its goal is to develop and commercialize new treatment options for age-related inflammatory conditions, with hemochromatosis as its initial clinical focus, and to thereafter expand the development of TELOMIR-1 to post-chemotherapy recovery as well as a broader range of other age-related inflammatory diseases and conditions such as osteoarthritis. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
www.telomirpharma.com
Sede
Tampa, Florida, USA
Fundado
-
Telomir Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker TELO. The last closing price for Telomir Pharmaceuticals was US$4.08. Over the last year, Telomir Pharmaceuticals shares have traded in a share price range of US$ 3.11 to US$ 9.39.

Telomir Pharmaceuticals currently has 29,762,671 shares in issue. The market capitalisation of Telomir Pharmaceuticals is US$121.43 million. Telomir Pharmaceuticals has a price to earnings ratio (PE ratio) of -7.97.

TELO Últimas noticias

Más noticias

Form 8-K - Current report
Edgar (US Regulatory)
19 Marzo 2025
TELO (11.76%)

Form EFFECT - Notice of Effectiveness
Edgar (US Regulatory)
02 Marzo 2025
TELO (11.76%)

Form 8-K - Current report
Edgar (US Regulatory)
25 Febrero 2025
TELO (11.76%)

Form 8-K - Current report
Edgar (US Regulatory)
20 Febrero 2025
TELO (11.76%)

Form 8-K - Current report
Edgar (US Regulatory)
18 Febrero 2025
TELO (11.76%)

Form S-3 - Registration statement under Securities Act of 1933
Edgar (US Regulatory)
14 Febrero 2025
TELO (11.76%)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Edgar (US Regulatory)
04 Febrero 2025
TELO (11.76%)

Form 5 - Annual statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
04 Febrero 2025
TELO (11.76%)

Form 8-K - Current report
Edgar (US Regulatory)
28 Enero 2025
TELO (11.76%)
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.61-11.96078431375.15.23183.911532894.34125472CS
40.3257.80312124854.1655.43.81437754.28346167CS
12-0.23-4.872881355934.725.43.75011300834.36127968CS
26-3.35-42.72959183677.847.893.1981500944.84845493CS
52-2.09-31.76291793316.589.393.111116395.26264283CS
156-2.51-35.8571428571720.723.111090925.54019109CS
260-2.51-35.8571428571720.723.111090925.54019109CS

TELO - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Telomir Pharmaceuticals?
El precio actual de las acciones de Telomir Pharmaceuticals es US$ 4.49
¿Cuántas acciones de Telomir Pharmaceuticals están en circulación?
Telomir Pharmaceuticals tiene 29,762,671 acciones en circulación
¿Cuál es la capitalización de mercado de Telomir Pharmaceuticals?
La capitalización de mercado de Telomir Pharmaceuticals es USD 121.43M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Telomir Pharmaceuticals?
Telomir Pharmaceuticals ha negociado en un rango de US$ 3.11 a US$ 9.39 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Telomir Pharmaceuticals?
El ratio precio/beneficio de Telomir Pharmaceuticals es -7.97
¿Cuál es la moneda de reporte de Telomir Pharmaceuticals?
Telomir Pharmaceuticals presenta sus resultados financieros en USD
¿Cuál es el último beneficio anual de Telomir Pharmaceuticals?
El último beneficio anual de Telomir Pharmaceuticals es USD -16.53M
¿Cuál es la dirección registrada de Telomir Pharmaceuticals?
La dirección registrada de Telomir Pharmaceuticals es 900 WEST PLATT STREET, SUITE 200, TAMPA, FLORIDA, 33606
¿Cuál es la dirección del sitio web de Telomir Pharmaceuticals?
La dirección del sitio web de Telomir Pharmaceuticals es www.telomirpharma.com
¿En qué sector industrial opera Telomir Pharmaceuticals?
Telomir Pharmaceuticals opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
SGLYSingularity Future Technology Ltd
US$ 1.6799
(143.43%)
30.76M
WINVWinVest Acquisition Corporation
US$ 25.00
(107.30%)
463
VVPRVivoPower International PLC
US$ 1.2899
(52.13%)
65.08M
RNAZTransCode Therapeutics Inc
US$ 1.12
(45.45%)
216.22M
GLTOGalecto Inc
US$ 6.00
(44.93%)
10.71M
YHCLQR House Inc
US$ 0.40
(-82.38%)
38.32M
KZIAKazia Therapeutics Ltd
US$ 0.9759
(-80.02%)
55.66k
DMNDamon Inc
US$ 0.0373
(-70.02%)
304.17M
TCBPTC BioPharm Holdings PLC
US$ 0.5046
(-67.23%)
5.9M
SOWGSow Good Inc
US$ 1.53
(-44.36%)
698.02k
DMNDamon Inc
US$ 0.0373
(-70.02%)
301.97M
NVDANVIDIA Corporation
US$ 117.70
(-0.70%)
259.06M
RNAZTransCode Therapeutics Inc
US$ 1.12
(45.45%)
215.3M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 9.03
(10.66%)
174.28M
HOLOMicroCloud Hologram Inc
US$ 1.00
(32.36%)
141.86M

TELO Discussion

Ver más
Monroe1 Monroe1 3 días hace
This is a much stronger stock than I previously thought. Added this morning before the run.
History in the making I do believe in time. This is a keeper in my book.
👍️0
Monroe1 Monroe1 3 días hace
I love Telomir too!! This is quite something.
09:31 AM EDT, 03/19/2025 (MT Newswires) -- Telomir Pharmaceuticals ( TELO ) said Wednesday that preclinical findings showed that Telomir-1 reduces tumor size by 50% in a prostate cancer animal model using "highly aggressive" human prostate cancer cells.

Telomir-1 "actively suppresses cancer growth rather than promoting it, and protects against chemotherapy-induced toxicity and mortality when combined with Paclitaxel," a chemotherapy drug that is often linked with severe toxicity and side effects, the company said.

Telomir said it is advancing Telomir-1 in several indications in addition to oncology. Studies are assessing the drug in age-related diseases like age-related macular degeneration and Wilson's disease, the company said.

The company said it plans to file an investigational new drug application by the end of the year.
👍️0
PinkPennies PinkPennies 4 semanas hace
TELO nice news a/h https://finance.yahoo.com/news/telomir-pharmaceuticals-seeks-tap-multi-210125422.html
👍️ 1
Monroe1 Monroe1 1 mes hace
There was coverage of Elon Musk and they made fun of him chewing tobacco or dipping snuff. Other honchos do it to...Bill Gates and more. But the article did not say why other than hinting a bad habit because he is with the new President.
Anyone want to know the real reason why he partakes in such a "nasty" habit???? Of course the MSM did not tell us why!!
👍️0
Monroe1 Monroe1 1 mes hace
Me too, been in it for many years now. science is solid and the pps has been stable and steady overall trending up slowly like an oak tree.
The whole area around telomeres should see steady gains...the future is incredible.
👍️0
PonkenPlonken PonkenPlonken 1 mes hace
I love Chromadex!
Do you use NR?

Regards
👍️0
Monroe1 Monroe1 2 meses hace
check this out. https://www.chromadex.com/ingredient/niagen/

Have a good day all day.
👍️0
PonkenPlonken PonkenPlonken 2 meses hace
I agree and think its a promising technology. I also believe as you fight aging, you fight cancer too.
My problem is these companies (GERN, MAIA and TELO) are as sketchy as it gets - speak of the promised land and deliver very little.
👍️0
Monroe1 Monroe1 2 meses hace
about half the time but the science of telomere elongation is well documented.
👍️0
PonkenPlonken PonkenPlonken 3 meses hace
Speak about mouse data as if its a clinical readout --- another telomere con
👍️0
PonkenPlonken PonkenPlonken 3 meses hace
Congrats - you are right i go by charts too...
but not when the PRs make me want to run in the opposite direction.
Seen to many of these cons pinged up to unload shares.
👍️0
TrendTrade2016 TrendTrade2016 3 meses hace
THEY CAN FIGURE IT OUT...WHILE I SPEND MY $$$...SOLD AT 7 BUCKS...RIDING VTYX BIO FOR THE DAY TOO
👍️0
TrendTrade2016 TrendTrade2016 3 meses hace
THE CHART SON...THE CHART...YOU THINK TOO MUCH
👍️0
PonkenPlonken PonkenPlonken 3 meses hace
If they figure it out, it can be a potent in anti-aging. I just dont believe any one of these companies is going to do that.
👍️0
PonkenPlonken PonkenPlonken 3 meses hace
Im aware of the telomere stuff from MAIA and GERN
both have that con-touch so i would never touch em

This is mouse data? Very rarely translates in humans
👍️0
TrendTrade2016 TrendTrade2016 3 meses hace
do you know what telomirs are
👍️0
TrendTrade2016 TrendTrade2016 3 meses hace
the more you think the more you lose
👍️0
PonkenPlonken PonkenPlonken 3 meses hace
why is this still running on the mouse data ?
👍️0
TrendTrade2016 TrendTrade2016 4 meses hace
TELO GAPPING
👍️0
PonkenPlonken PonkenPlonken 4 meses hace
Is in mouse - con
👍️0
PonkenPlonken PonkenPlonken 4 meses hace
Eyy boss.......... you bite this telomere stuff?
MAIA GERN are others... i dislike both -- TELO looks promising
"Reverse" type 2 diabetes == cure....... big words
👍️0
TrendTrade2016 TrendTrade2016 4 meses hace
TELO READY TO FLY LOVE THSI BIO
👍️0
TrendTrade2016 TrendTrade2016 7 meses hace
TELO/////PUSH PUSH
👍️0
TrendTrade2016 TrendTrade2016 7 meses hace
TELO 6.20 lol. Precision charting
👍️0
TrendTrade2016 TrendTrade2016 7 meses hace
TELO...6.20 MAGNET....
👍️0
TrendTrade2016 TrendTrade2016 7 meses hace
TELOMIRS ARE THE DNA TAILS THAT DETERMINE LONGEVITY AND DEATH, THE MORE YOUR TELEMIRS RETRACT, THE SOONER YOU DIE!!!
👍️0
Awl416 Awl416 7 meses hace
Halt up
👍️0
PStockPickz PStockPickz 1 año hace
Monster
👍️0

Su Consulta Reciente

NASDAQ
TELO
Telomir Pharmaceuticals
BIT
P1JO88
BNP Paribas Issuance BV
NASDAQ
GPACW
Global Partner Acqusitio...
USOTC
FDENF
La Francaise de l Energie (PK)
NASDAQ
LMFAW
LM Funding America
KUCN
SEIUSDT
Sei
USOTC
FTGPF
First Trust Global Funds... (GM)
BOV
DMVF3M
D1000 Varejo Farma Parti... ON
COIN
ASXETH
Asymetrix Governance Token
TSXV
NIKL.H
GK Resources
COIN
BABALUSD
ALIBABA
AMEX
AULT-D
Ault Alliance
NASDAQ
AMTB
Amerant Bancorp
NASDAQ
QLGN
Qualigen Therapeutics
EU
VIE
Veolia Environnement
NASDAQI
BXN
Cboe NASDAQ 100 BuyWrite
Delayed Upgrade Clock
ADVFN Logo
México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados

Quitar anuncios

Suscríbete a una experiencia sin publicidad

Sin anuncios

Pruébalo ahora

Mantenga los anuncios